The effect of telithromycin on inflammatory markers in chronic obstructive pulmonary diseases
Full Text (PDF)
Taha Bekçi 1 * , Ercan Kurtipek 1, Recep Kesli 2, Emin Maden 3, Turgut Teke 3
More Detail
1 Konya Training and Research Hospital, Pulmonology Department, Konya, Turkey2 Konya Training and Research Hospital, Microbiology Department, Konya, Turkey3 Selçuk University, Meram Medical Faculty, Department of Pulmonary Medicine, Konya, Turkey* Corresponding Author

Abstract

Aim: To evaluate the anti-inflammatory effect of telithromycin on sputum interleukin-8 (IL-8), tumor necrosis factor-α (TNF-α), myeloperoxidase (MPO) levels in patient with chronic obstructive pulmonary diseases (COPD). Methods: Thirty four patients with mild to moderate COPD were enrolled in this prospective, single center, double-blind, placebo controlled study. Subjects received either telithromycin or placebo for 10 days. Before and after treatment period spirometric tests, arterial blood gas analyses were performed, sputum samples were taken for measurement of sputum inflammatory markers, and sputum was induced. Results: There was no statistical difference in baseline clinical or laboratory parameters between groups. After the treatment, the induced sputum IL-8, TNF-α, MPO levels is similar compared with pretreatment levels. Conclusion: In this study, anti-inflammatory effects of telithromycin in stable COPD patients were not demonstrated. Further studies are needed to determine the clinical significance of these findings.

Keywords

License

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Article Type: Original Article

EUR J GEN MED, Volume 6, Issue 4, October 2009, 218-222

https://doi.org/10.29333/ejgm/82673

Publication date: 15 Oct 2009

Article Views: 1211

Article Downloads: 731

Open Access References How to cite this article